BRPI0924887A2 - Compostos de fenilalquil-imidazol-bifosfonato - Google Patents

Compostos de fenilalquil-imidazol-bifosfonato

Info

Publication number
BRPI0924887A2
BRPI0924887A2 BRPI0924887-0A BRPI0924887A BRPI0924887A2 BR PI0924887 A2 BRPI0924887 A2 BR PI0924887A2 BR PI0924887 A BRPI0924887 A BR PI0924887A BR PI0924887 A2 BRPI0924887 A2 BR PI0924887A2
Authority
BR
Brazil
Prior art keywords
phenylalkyl
imidazole
bisphosphonate compounds
bisphosphonate
compounds
Prior art date
Application number
BRPI0924887-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Simona Cotesta
Wolfgang Jahke
Jean-Michel Rondeau
Sven Weiler
Leo Widler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0924887A2 publication Critical patent/BRPI0924887A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0924887-0A 2008-12-23 2009-12-21 Compostos de fenilalquil-imidazol-bifosfonato BRPI0924887A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08172824 2008-12-23
US14275509P 2009-01-06 2009-01-06
PCT/EP2009/067679 WO2010076258A1 (en) 2008-12-23 2009-12-21 Phenylalkyl-imidazole-bisphosphonate compounds

Publications (1)

Publication Number Publication Date
BRPI0924887A2 true BRPI0924887A2 (pt) 2015-07-07

Family

ID=40595694

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924887-0A BRPI0924887A2 (pt) 2008-12-23 2009-12-21 Compostos de fenilalquil-imidazol-bifosfonato

Country Status (11)

Country Link
US (1) US20110257131A1 (https=)
EP (1) EP2382223A1 (https=)
JP (1) JP2012513443A (https=)
KR (1) KR20110110219A (https=)
CN (1) CN102264752A (https=)
AU (1) AU2009334889A1 (https=)
BR (1) BRPI0924887A2 (https=)
CA (1) CA2746612A1 (https=)
EA (1) EA201100964A1 (https=)
MX (1) MX2011006605A (https=)
WO (1) WO2010076258A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9273357B2 (en) 2011-04-04 2016-03-01 The Trustees Of Columbia University In The City Of New York Pharmacogenetic test anti-resorptive therapy-associated osteonecrosis of the jaw
WO2016081281A1 (en) * 2014-11-17 2016-05-26 Salk Institute For Biological Studies Lipophilic bisphosphonates and methods of use
CN109608492B (zh) * 2018-12-19 2021-02-09 深圳市第二人民医院 一种用于骨质疏松的二膦酸化合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3626058A1 (de) * 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ES2038692T4 (es) * 1986-11-21 2012-02-10 Novartis Ag Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos.
JPH05148279A (ja) * 1991-08-01 1993-06-15 Kaken Pharmaceut Co Ltd ビスホスホン酸誘導体
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
US8012949B2 (en) * 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
US7687482B2 (en) * 2006-03-17 2010-03-30 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
EP1802641B8 (en) * 2004-10-08 2012-03-07 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US20080255366A1 (en) * 2005-09-12 2008-10-16 Dr. Reddy's Laboratories Limited Crystalline Trihydrate of Zoledronic Acid
AR063121A1 (es) * 2006-10-05 2008-12-30 Novartis Ag Composicion farmaceutica

Also Published As

Publication number Publication date
AU2009334889A1 (en) 2011-06-30
CA2746612A1 (en) 2010-07-08
EA201100964A1 (ru) 2012-02-28
WO2010076258A1 (en) 2010-07-08
EP2382223A1 (en) 2011-11-02
KR20110110219A (ko) 2011-10-06
US20110257131A1 (en) 2011-10-20
MX2011006605A (es) 2011-06-30
JP2012513443A (ja) 2012-06-14
CN102264752A (zh) 2011-11-30

Similar Documents

Publication Publication Date Title
BRPI0914254A2 (pt) compostos anti-infectivos
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt) compostos
DK2242759T3 (da) Forbindelser
BRPI0917369A2 (pt) Compostos inseticidas
BRPI0918500A2 (pt) compostos inseticidas
BRPI0917188A2 (pt) Compostos inseticidas
SMT201500117B (it) Composti antibatterici
DK2080901T3 (da) Vindmølle-vindmålings-kompensation
DK2376490T3 (da) Imidazopyridinforbindelser
BRPI0914775A2 (pt) compostos de fenila dissubstituídos
BRPI0913966A2 (pt) compostos orgânicos
BRPI0914698A2 (pt) compostos orgânicos
BRPI0909417A2 (pt) compostos orgânicos
BRPI0915018A2 (pt) compostos orgânicos
DK2310359T3 (da) Organiske forbindelser
DK2308869T3 (da) Azolforbindelse
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
BRPI0907611A2 (pt) Compostos orgânicos
BRPI0906705A2 (pt) Composto heterocíclicos
BRPI0922464A2 (pt) Combinações de compostos ativos
BRPI0912475A8 (pt) compostos como inibidores de quinase
BRPI0914942A2 (pt) Compostos de oxindol
DK2310613T3 (da) Forbedret brudled til stigrør
BRPI0916432A2 (pt) compostos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2326 DE 04-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.